Valuation: Sysmex Corporation

Market Cap 991B 6.05B 5.31B 4.95B 4.55B 8.53B 578B 8.67B 58.68B 22.97B 287B 22.72B 22.23B P/E 2027 *
24.7x
P/E 2028 * 20.2x
Enterprise Value 1,009B 6.16B 5.41B 5.04B 4.63B 8.69B 589B 8.84B 59.77B 23.39B 292B 23.14B 22.64B EV / Sales 2027 *
1.88x
EV / Sales 2028 * 1.78x
Free-Float
72.3%
Yield 2027 *
2.36%
Yield 2028 * 2.46%
1 day+2.26%
1 week+7.97%
Current month+13.74%
1 month+12.51%
3 months+21.37%
6 months+16.15%
Current year+8.43%
1 week 1,494
Extreme 1494
1,683
1 month 1,449.5
Extreme 1449.5
1,683
Current year 1,246
Extreme 1246
1,683
1 year 1,246
Extreme 1246
2,529.5
3 years 1,246
Extreme 1246
3,243
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 76 01/04/2018
Director of Finance/CFO 56 -
President 65 01/04/2026
Director TitleAgeSince
Chairman 76 01/04/2013
Director/Board Member 65 01/06/2019
Director/Board Member 71 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+2.26%+7.97%-33.37%-47.87% 6.05B
+2.66%+7.63%-15.10%-4.84% 187B
+3.16%+5.50%-5.53%-1.55% 111B
+2.71%+5.45%+11.66%+71.30% 62.18B
+0.34%-5.11%+24.82%+43.77% 48.4B
+4.67%+8.13%-9.07%-40.66% 45.83B
+2.04%+3.63% - - 34.26B
+2.02%+0.13%-16.40%-43.46% 28.88B
+1.74%-6.19%+30.74%-7.79% 23.72B
+5.47%+8.78%+1.68%+0.13% 22.45B
Average +2.22%+1.60%-1.17%-3.44% 56.98B
Weighted average by Cap. +1.48%+3.87%-3.43%+3.52%

Financials

2027 *2028 *
Net sales 535B 3.27B 2.87B 2.67B 2.46B 4.61B 313B 4.69B 31.71B 12.41B 155B 12.28B 12.02B 566B 3.45B 3.03B 2.82B 2.6B 4.87B 330B 4.95B 33.49B 13.11B 164B 12.97B 12.69B
Net income 41.2B 252M 221M 206M 189M 355M 24.05B 361M 2.44B 955M 11.92B 945M 924M 49.45B 302M 265M 247M 227M 426M 28.86B 433M 2.93B 1.15B 14.31B 1.13B 1.11B
Net Debt 18.45B 113M 98.89M 92.08M 84.7M 159M 10.76B 161M 1.09B 428M 5.34B 423M 414M 16.07B 98.18M 86.17M 80.24M 73.8M 138M 9.38B 141M 952M 373M 4.65B 369M 361M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,861
Date Price Change Volume
29/07/26 JP¥1,672.50 +2.26% 3,209,700
28/07/26 JP¥1,635.50 +1.84% 3,025,300
27/07/26 JP¥1,606.00 +4.97% 2,535,000
24/07/26 JP¥1,530.00 +1.26% 1,663,800
23/07/26 JP¥1,511.00 -2.45% 2,238,000
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,635.50JPY
Average target price
1,738.57JPY
Spread / Average Target
+6.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6869 Stock